Brief: ExpreS2ion Biotech Holding Resolves On Rights Issue Of Units For About SEK 53 Mln
07/04/2026 07:38
April 7 (Reuters) - ExpreS2ion Biotech Holding AB EXPRS2.ST: BOARD OF DIRECTORS OF EXPRES2ION HAS RESOLVED ON A RIGHTS ISSUE OF UNITS OF APPROXIMATELY SEK 53 MILLION SUBSCRIPTION PRICE SET AT SEK 1.60 PER UNIT IN RIGHTS ISSUE SHAREHOLDERS TO RECEIVE 47 UNIT RIGHTS PER SHARE ON 14 APRIL 2026 RIGHTS ISSUE COVERED UP TO SEK 32 MILLION, ABOUT 60 PERCENT OF TOTAL Source text: ID:nMFNbctwDH Further company coverage: EXPRS2.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))
Recent news on ExpreS2ion Biotech Holding AB
See all newsBrief: Expres2ion Biotech To Raise SEK 19.3 Million From Warrants And Share Issue
Brief: ExpreS2ion Reports Q2 Loss Of SEK 9.7 Million
Brief: Expres2ion Biotech Says DSMB Recommends Expanding 450 Μg Cohort
Brief: Expres2ion Biotech Holding Q1 2026 Operating Income SEK 6.87 Mln
Brief: Expres2ion Updates ES2B-C001 Phase I Programme and Reports Additional Preliminary Immunogenicity and Safety Observations